1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.07. | Cano Health has emerged from bankruptcy, company says | 2 | FierceHealthcare | ||
| 01.07. | Cano Health, Inc. - 15-12G, Securities registration termination | 1 | SEC Filings | ||
| 28.06. | Cano Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.05. | Cano Health, Inc.: Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan | 125 | PR Newswire | Emergence from Chapter 11 Expected in Third Quarter of 2024
MIAMI, May 21, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company"), a leading value-based primary care... ► Artikel lesen | |
| 05.02. | NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings | 394 | PR Newswire | MIAMI, Feb. 5, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company") announced today that on February 5, 2024, the New York Stock Exchange (the "NYSE") notified the... ► Artikel lesen | |
| 05.02. | Cano Health, Inc.: Cano Health Enters Restructuring Support Agreement with a Significant Majority of its Lenders to Strengthen Financial Position | 338 | PR Newswire | Positions the Company to Advance Its Ongoing Transformation Plan Designed to Significantly Reduce Costs, Enhance Productivity, and Improve Cash Flow
Receives Commitment for $150 Million in New Capital... ► Artikel lesen | |
| CANO HEALTH Aktie jetzt für 0€ handeln | |||||
| 29.12.23 | Cano Health, Inc.: Cano Health Receives NYSE Notice of Non-Compliance with Market Capitalization Criteria | 1.193 | PR Newswire | Accelerates Transformation Plan, Now Targeting $290 million of Cost Reductions
MIAMI, Dec. 29, 2023 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company") announced today... ► Artikel lesen |
7 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 506,80 | +0,06 % | BRISANTE Meldung setzt Intuitive Surgical Aktionäre unter Zugzwang. Bitte reagieren Sie jetzt sofort! | ||
| ROKU | 75,73 | +0,03 % | Roku Soars 44.2% in 6 Months: Analyzing the Stock's 2025 Prospects | ||
| ATOSSA THERAPEUTICS | 0,950 | -1,66 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Full Results from Phase 2 KARISMA-Endoxifen Study Demonstrating Statistically Significant Reductions in Mammographic Breast Density | 1 MG Dose (Z)-Endoxifen Shows Potential as a Well-Tolerated, Preventative Therapy for Premenopausal Women at Risk of Developing Breast Cancer Data to be Presented in a Poster Spotlight Session During... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| QUIDELORTHO | 42,000 | -2,33 % | Does QuidelOrtho Corporation (QDEL) Have Healthy Long-Term Growth Prospects? | ||
| CENTENE | 57,31 | -1,02 % | Hedge Fund and Insider Trading News: Chris Hohn, Seth Klarman, Warren Buffett, Third Point, Palliser Capital, Centene Corp (CNC), Salesforce Inc (CRM), and More | ||
| TEMPEST THERAPEUTICS | 0,815 | +0,25 % | Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| VERU | 0,611 | -2,24 % | Veru (NASDAQ:VERU) Receives "Buy" Rating from HC Wainwright | ||
| FULGENT GENETICS | 17,600 | -1,68 % | Fulgent Reports Third Quarter 2024 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen | |
| NANO-X IMAGING | 7,055 | -0,21 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| LANTHEUS | 86,26 | -1,35 % | AKTIONÄR-Tipp Lantheus: Goldman rät zum Kauf | Wachstumssorgen um das radiopharmazeutische Diagnostik-Produkt Pylarify haben der Aktie von Lantheus zuletzt zugesetzt. Geht es nach den Analysten von Goldman Sachs, so sind diese Zweifel nicht gerechtfertigt.... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 2,900 | -4,61 % | Perspective Therapeutics, Inc.: Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-a-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society ... | [212Pb]VMT-a-NET continued to have a favorable safety profile, with no dose-limiting toxicities observed at the two doses tested (2.5 and 5.0 mCi)Eight of nine patients had durable control of disease.... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 21,200 | +0,95 % | AMN Healthcare Services (NYSE:AMN) Reaches New 1-Year Low - Here's What Happened | ||
| OMNICELL | 42,200 | -1,40 % | Omnicell Announces Third Quarter 2024 Results | FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy care delivery model, today... ► Artikel lesen | |
| ALPHATEC | 8,850 | +6,63 % | Pre-market Movers: Root, Inc., Autonomix Medical, Avadel Pharmaceuticals, Estée Lauder, Alphatec Holdings | DUBLIN (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 09.10 A.M. ET).In the Green Root, Inc. (ROOT) is up over 94% at $78.85.
Autonomix... ► Artikel lesen |
Das Unternehmen CANO HEALTH INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,310 Euro und damit 0,00 % im Plus.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANO HEALTH INC finden Sie auf Wallstreet Online.
